OrthoPediatrics Buys ApiFix Ltd.

OrthoPediatrics Buys ApiFix Ltd.

Deals that were in the pipeline prior to the Covid-19 pandemic are still closing, particularly on the technology side of health care. OrthoPediatrics Corp. (NASDAQ: KIDS) announced its acquisition of Israeli orthopedic device maker ApiFix Ltd. on April 1 for approximately $36 million. OrthoPediatrics provides products to the pediatric orthopedic market, such as trauma and deformity correction, scoliosis and sports medicine, in the United States and 41 countries. It went public in October 2017, raising $52 million as a company serving the previously neglected field of children’s orthopedics and implants. Revenues in 2019 were up 59%, to $76.6 million, compared with $45.6 million for... Read More »
Align Technology Bites for Exocad Global

Align Technology Bites for Exocad Global

Align Technology, Inc. (NASDAQ: ALGN), best known for its Invisalign system, acquired exocad Global Holdings GmbH in March. The price was approximately $407 million (EUR376 million). Exocad, based in Darmstadt, Germany, is a global provider of dental CAD/CAM software market and offers fully integrated workflows to dental labs and dental practices via a broad customer base of partners, and resellers in over 150 countries. It was a portfolio company of Carlyle Europe Technology Partners. The deal has many benefits for Align. First, it strengthens Align’s digital platform that delivers tools and features for diagnostic, restorative, implant, and orthodontic workflows. It also adds exocad’s... Read More »
Orthofix Medical Adds the Fitbone Limb Lengthening System

Orthofix Medical Adds the Fitbone Limb Lengthening System

Orthofix Medical Inc. (NASDAQ: OFIX), a global medical device company focused on musculoskeletal healing products, extended its product line with a deal for the Fitbone limb lengthening system. Privately held Wittenstein SE, based in Igersheim, Germany, will get $18 million in cash and a manufacturing supply contract. The Fitbone intramedullary lengthening system is designed to lengthen femur and tibia bones. More than 3,500 cases in 15 countries have been performed with the technology. This transaction brings other potential applications of the technology, which are in preliminary development, including the Fitspine system for early onset scoliosis. Texas-based Orthofix, formerly known as... Read More »
Hot Healthcare Sectors for Investment, Growth & Consolidation in 2020

Hot Healthcare Sectors for Investment, Growth & Consolidation in 2020

Every year, starting in November, the crystal balls come out and the prognostications begin. What will the new year bring? Who or what will make out better and who or what will not? We talked with Gary Herschman, a member of Epstein Becker Green’s Healthcare and Life Sciences practice, about the healthcare sectors he and his firm are watching in 2020. Here are their predictions for 2020. Health Care M&A: What do you see as the biggest themes in the healthcare industry this year? There are a lot of moving parts, from the discovery of new drugs to the shifting attention to post-acute care. Gary Herschman: We see three key “drivers” of health industry transformation that are already... Read More »
Anika Therapeutics, Inc. Announces Double Purchase

Anika Therapeutics, Inc. Announces Double Purchase

Anika Therapeutics, Inc. (NASDAQ: ANIK), a medical device company that develops therapeutic products for tissue protection, healing and repair, announced two acquisitions in mid-Januaryto bolster its device portfolio. For a modest sum of $35 million upfront and a potential $60 million in milestones, the company acquired Parcus Medical, LLC, which provides implant and instrumentation products used by surgeons to repair and reconstruct damaged ligaments and tendons due to sports injuries, trauma and disease. The deal will help expand Anika’s offerings into the ambulatory surgical center (ASC) market.  Parcus reported $12.5 million in revenue in 2019. Anika also acquired Arthrosurface for $60... Read More »
2019’s Biggest Healthcare Deals, by Sector

2019’s Biggest Healthcare Deals, by Sector

2020 has just begun, which means it’s time to look back at the healthcare M&A landscape of 2019. Just three days into the new year, nearly 1,780 deals are already on the books for 2019. More deals will turn up as we search our many sources, but the number likely won’t top the record of 1,900-plus set in 2018. Thanks to the multi-billion-dollar deals announced in the Biotech and Pharmaceutical sectors, 2019 will set a new spending record. Preliminary data show $399.1 billion was spent on healthcare acquisitions last year, about 20% higher than in 2018. We expect that number to rise as we go through the year and the 10Ks and quarterly reports come out. It’s possible the... Read More »